Company Recognized For Its Work on Traumatic Brain Injury / Concussion
BETHESDA, MD. December 6th, 2012 – BrainScope® Company, Inc. announced today that it received the Verl Zanders Emerging Business of the Year Award by the Montgomery County Chamber of Commerce (MCCC) last evening at the 2012 MCCC Business Awards Dinner & Reception. The event was attended by over 700 business and government leaders. Among the seven awards presented during the evening were esteemed recipients such as J.W. Marriott, Jr. (Emeritus Business Leader), Booz Allen Hamilton (Prime Partner of the Year), and Lockheed Martin (Corporate Achievement).
"We are greatly honored and humbled to receive this award. We would not be here without the significant support of our partner, the U.S. Department of Defense," stated Michael Singer, President and CEO of BrainScope. "The men and women who risk their lives every day for our country are our inspiration, and we owe it to them to continue our work in developing a device to assess traumatic brain injury and concussion at the point of care."
"Over the years, the Montgomery County Chamber of Commerce has recognized remarkable companies that have grown to become leaders in their fields," commented Georgette "Gigi" Godwin, President and CEO of MCCC. "Past winners of the Verl Zanders Emerging Business of the Year Award have included Qiagen, MedImmune and Honest Tea. The selection committee was impressed by BrainScope's progress and its prospects for helping soldiers, athletes and individuals suffering from concussions and other brain injuries."
In the last year, BrainScope has been awarded research and development contracts valued in excess of $10 million by the U.S. Department of Defense. In May 2011 BrainScope reached concurrence with the U.S. Food and Drug Administration (FDA) on the key study design elements for clinical validation of the Ahead® M-100 medical device.
Since 2010, results from clinical studies utilizing BrainScope's technology have been published in leading peer-reviewed neurology and emergency medicine journals such as Brain Injury, The Journal of Head Trauma Rehabilitation and The American Journal of Emergency Medicine.
Backed by Revolution (created by AOL co-founder Steve Case), Shaman Ventures, ZG Ventures, Maryland Venture Fund and Brain Trust Accelerator Fund, BrainScope is a medical neurotechnology company that is developing a new generation of hand-held, easy-to-use, non-invasive instruments designed to aid medical professionals in rapidly and objectively assessing brain function. BrainScope devices in development are based on a proprietary technology platform, which integrates databases of brainwave recordings with advanced digital signal processing, sophisticated algorithms, miniaturized hardware and disposable headset sensors. The company's initial focus is on traumatic brain injury and its milder presentation, commonly referred to as "concussion". BrainScope's unique devices are being created to meet a long-standing clinical need for improved early identification, staging and triage of head injured patients. BrainScope devices under development for assessment of traumatically-induced head injury and concussion are for investigational use only and have not been submitted to FDA for premarket review. For more information, please visit www.brainscope.com.